Recombinant Proteins Market (By Host Cell: Insect Cells, Mammalian; By Application: Research, Therapeutics; By Product & Services; By End-user) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Recombinant Proteins Market 

5.1. COVID-19 Landscape: Recombinant Proteins Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Recombinant Proteins Market, By Product & Services Scope

8.1. Recombinant Proteins Market, by Product & Services Scope, 2022-2030

8.1.1. Product

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Production Services

8.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Recombinant Proteins Market, By Application Scope

9.1. Recombinant Proteins Market, by Application Scope, 2022-2030

9.1.1. Drug Discovery & Development

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Therapeutics

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Research

9.1.3.1. Market Revenue and Forecast (2017-2030)

9.1.4. Others

9.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Recombinant Proteins Market, By End-user Scope 

10.1. Recombinant Proteins Market, by End-user Scope, 2022-2030

10.1.1. Pharma & Biotechnology Companies

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Academic & Research Institutes

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Diagnostic Laboratories

10.1.3.1. Market Revenue and Forecast (2017-2030)

10.1.4. Others

10.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Recombinant Proteins Market, By Host Cell Scope 

11.1. Recombinant Proteins Market, by Host Cell Scope, 2022-2030

11.1.1. Mammalian Systems

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Insect Cells

11.1.2.1. Market Revenue and Forecast (2017-2030)

11.1.3. Yeast & Fungi

11.1.3.1. Market Revenue and Forecast (2017-2030)

11.1.4. Bacterial Cells

11.1.4.1. Market Revenue and Forecast (2017-2030)

11.1.5. Others

11.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Recombinant Proteins Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Product & Services Scope (2017-2030)

12.1.2. Market Revenue and Forecast, by Application Scope (2017-2030)

12.1.3. Market Revenue and Forecast, by End-user Scope (2017-2030)

12.1.4. Market Revenue and Forecast, by Host Cell Scope (2017-2030)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Product & Services Scope (2017-2030)

12.1.5.2. Market Revenue and Forecast, by Application Scope (2017-2030)

12.1.5.3. Market Revenue and Forecast, by End-user Scope (2017-2030)

12.1.5.4. Market Revenue and Forecast, by Host Cell Scope (2017-2030)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Product & Services Scope (2017-2030)

12.1.6.2. Market Revenue and Forecast, by Application Scope (2017-2030)

12.1.6.3. Market Revenue and Forecast, by End-user Scope (2017-2030)

12.1.6.4. Market Revenue and Forecast, by Host Cell Scope (2017-2030)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Product & Services Scope (2017-2030)

12.2.2. Market Revenue and Forecast, by Application Scope (2017-2030)

12.2.3. Market Revenue and Forecast, by End-user Scope (2017-2030)

12.2.4. Market Revenue and Forecast, by Host Cell Scope (2017-2030)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Product & Services Scope (2017-2030)

12.2.5.2. Market Revenue and Forecast, by Application Scope (2017-2030)

12.2.5.3. Market Revenue and Forecast, by End-user Scope (2017-2030)

12.2.5.4. Market Revenue and Forecast, by Host Cell Scope (2017-2030)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Product & Services Scope (2017-2030)

12.2.6.2. Market Revenue and Forecast, by Application Scope (2017-2030)

12.2.6.3. Market Revenue and Forecast, by End-user Scope (2017-2030)

12.2.6.4. Market Revenue and Forecast, by Host Cell Scope (2017-2030)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Product & Services Scope (2017-2030)

12.2.7.2. Market Revenue and Forecast, by Application Scope (2017-2030)

12.2.7.3. Market Revenue and Forecast, by End-user Scope (2017-2030)

12.2.7.4. Market Revenue and Forecast, by Host Cell Scope (2017-2030)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Product & Services Scope (2017-2030)

12.2.8.2. Market Revenue and Forecast, by Application Scope (2017-2030)

12.2.8.3. Market Revenue and Forecast, by End-user Scope (2017-2030)

12.2.8.4. Market Revenue and Forecast, by Host Cell Scope (2017-2030)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Product & Services Scope (2017-2030)

12.3.2. Market Revenue and Forecast, by Application Scope (2017-2030)

12.3.3. Market Revenue and Forecast, by End-user Scope (2017-2030)

12.3.4. Market Revenue and Forecast, by Host Cell Scope (2017-2030)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Product & Services Scope (2017-2030)

12.3.5.2. Market Revenue and Forecast, by Application Scope (2017-2030)

12.3.5.3. Market Revenue and Forecast, by End-user Scope (2017-2030)

12.3.5.4. Market Revenue and Forecast, by Host Cell Scope (2017-2030)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Product & Services Scope (2017-2030)

12.3.6.2. Market Revenue and Forecast, by Application Scope (2017-2030)

12.3.6.3. Market Revenue and Forecast, by End-user Scope (2017-2030)

12.3.6.4. Market Revenue and Forecast, by Host Cell Scope (2017-2030)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Product & Services Scope (2017-2030)

12.3.7.2. Market Revenue and Forecast, by Application Scope (2017-2030)

12.3.7.3. Market Revenue and Forecast, by End-user Scope (2017-2030)

12.3.7.4. Market Revenue and Forecast, by Host Cell Scope (2017-2030)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Product & Services Scope (2017-2030)

12.3.8.2. Market Revenue and Forecast, by Application Scope (2017-2030)

12.3.8.3. Market Revenue and Forecast, by End-user Scope (2017-2030)

12.3.8.4. Market Revenue and Forecast, by Host Cell Scope (2017-2030)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Product & Services Scope (2017-2030)

12.4.2. Market Revenue and Forecast, by Application Scope (2017-2030)

12.4.3. Market Revenue and Forecast, by End-user Scope (2017-2030)

12.4.4. Market Revenue and Forecast, by Host Cell Scope (2017-2030)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Product & Services Scope (2017-2030)

12.4.5.2. Market Revenue and Forecast, by Application Scope (2017-2030)

12.4.5.3. Market Revenue and Forecast, by End-user Scope (2017-2030)

12.4.5.4. Market Revenue and Forecast, by Host Cell Scope (2017-2030)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Product & Services Scope (2017-2030)

12.4.6.2. Market Revenue and Forecast, by Application Scope (2017-2030)

12.4.6.3. Market Revenue and Forecast, by End-user Scope (2017-2030)

12.4.6.4. Market Revenue and Forecast, by Host Cell Scope (2017-2030)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Product & Services Scope (2017-2030)

12.4.7.2. Market Revenue and Forecast, by Application Scope (2017-2030)

12.4.7.3. Market Revenue and Forecast, by End-user Scope (2017-2030)

12.4.7.4. Market Revenue and Forecast, by Host Cell Scope (2017-2030)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Product & Services Scope (2017-2030)

12.4.8.2. Market Revenue and Forecast, by Application Scope (2017-2030)

12.4.8.3. Market Revenue and Forecast, by End-user Scope (2017-2030)

12.4.8.4. Market Revenue and Forecast, by Host Cell Scope (2017-2030)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Product & Services Scope (2017-2030)

12.5.2. Market Revenue and Forecast, by Application Scope (2017-2030)

12.5.3. Market Revenue and Forecast, by End-user Scope (2017-2030)

12.5.4. Market Revenue and Forecast, by Host Cell Scope (2017-2030)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Product & Services Scope (2017-2030)

12.5.5.2. Market Revenue and Forecast, by Application Scope (2017-2030)

12.5.5.3. Market Revenue and Forecast, by End-user Scope (2017-2030)

12.5.5.4. Market Revenue and Forecast, by Host Cell Scope (2017-2030)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Product & Services Scope (2017-2030)

12.5.6.2. Market Revenue and Forecast, by Application Scope (2017-2030)

12.5.6.3. Market Revenue and Forecast, by End-user Scope (2017-2030)

12.5.6.4. Market Revenue and Forecast, by Host Cell Scope (2017-2030)

Chapter 13. Company Profiles

13.1. Abcam plc.

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Sino Biological, Inc.

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. R&D Systems, Inc.

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. GenScript

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Bio-Rad Laboratories, Inc.

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Merck KGaA

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Thermo Fisher Scientific

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Proteintech Group, Inc.

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Enzo Life Sciences, Inc.

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Abnova Corp.

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms